Evidence map›Paper›PMID 26186100›Full record

ReviewHuman vaccines & immunotherapeutics2015

Dissecting the indirect effects caused by vaccines into the basic elements.

Carla D Scarbrough Lefebvre, Augustin Terlinden, Baudouin Standaert

Abstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Strong Herd Effects of Human Papillomavirus Vaccination.The Journal of infectious diseases · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung · 2021
    Review
  12. Article
  13. Vaccines for COVID-19.Clinical and experimental immunology · 2020
    Review
  14. Article
  15. Article
  16. Vaccine confidence: the keys to restoring trust.Human vaccines & immunotherapeutics · 2020
    Article
  17. Article
  18. Vaccine-associated hypersensitivity.The Journal of allergy and clinical immunology · 2018
    Review
  19. Article
  20. 2. How is the economic assessment of vaccines performed today?Journal of market access & health policy · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carla D Scarbrough Lefebvrea External Consultant ; Kiowa , CO USA.
Augustin Terlinden
Baudouin Standaert

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination directly protects vaccinated individuals, but it also has the potential for indirectly protecting the unvaccinated in a population (herd protection). Unintended negative consequences such as the re-manifestation of infection, mainly expressed as age shifts, result from vaccination programs as well. We discuss the necessary conditions for achieving optimal herd protection (i.e., high quality vaccine-induced immunity, substantial effect on the force of infection, and appropriate vaccine coverage and distribution), as well as the conditions under which age shifts are likely to occur. We show examples to illustrate these effects. Substantial ambiguity in observing and quantifying these indirect vaccine effects makes accurate evaluation troublesome even though the nature of these outcomes may be critical for accurate assessment of the economic value when decision makers are evaluating a novel vaccine for introduction into a particular region or population group. More investigation is needed to identify and develop successful assessment methodologies for precisely analyzing these outcomes.

Indexed as

Drug-Related Side Effects and Adverse ReactionsImmunity, HerdHumansVaccinesVaccinesage shiftclusteringexternalitiesforce of infectionherd protectionrebound effectsserotype replacementvaccination

Identifiers

PMID26186100
PMCPMC4635729

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.